KRMD icon

KORU Medical Systems

3.92 USD
-0.10
2.49%
At close Updated Sep 12, 4:00 PM EDT
1 day
-2.49%
5 days
-4.39%
1 month
-5.54%
3 months
22.5%
6 months
19.51%
Year to date
0.77%
1 year
55.56%
5 years
-50.63%
10 years
-1.26%
 

About: KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Employees: 80

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

57% more capital invested

Capital invested by funds: $44.3M [Q1] → $69.5M (+$25.1M) [Q2]

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

4.08% more ownership

Funds ownership: 37.96% [Q1] → 42.04% (+4.08%) [Q2]

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

0% more funds holding

Funds holding: 79 [Q1] → 79 (+0) [Q2]

Financial journalist opinion

Positive
Zacks Investment Research
17 days ago
Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice
Does KORU Medical Systems, Inc. (KRMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice
Neutral
GlobeNewsWire
17 days ago
Cirtec Medical Announces Appointment of New Chief Executive Officer
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025.
Cirtec Medical Announces Appointment of New Chief Executive Officer
Neutral
Seeking Alpha
1 month ago
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Linda M. Tharby - President, CEO & Director Thomas Adams - CFO, Secretary & Treasurer Conference Call Participants Anderson Schock - B.
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KORU Medical Systems, Inc. (KRMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.02 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
Neutral
Business Wire
1 month ago
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2025. Financial Highlights •   Second quarter 2025 net revenues of $10.2 million, a 21% increase over the prior year period       •   Core bus.
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
Neutral
Business Wire
1 month ago
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten w.
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Business Wire
1 month ago
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on August 13th, 2025. KORU Medical's management is scheduled to present at the Canaccord Genuity 45th An.
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
Neutral
Business Wire
1 month ago
KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2025 financial results on Wednesday, August 6, 2025. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discus.
KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
Neutral
Business Wire
2 months ago
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Adam Kalbermatten as Chief Commercial Officer, effective July 28, 2025. Adam brings over two decades of commercial leadership experience in.
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
Neutral
Business Wire
3 months ago
KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company is set to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the Russell indexes annual reconstitution, effective after the US.
KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes
Charts implemented using Lightweight Charts™